Back
Alumis Inc. ALMS · Insights
Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercializ... Price6.55
Market Cap847.8 M
Float91.35 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro